Bone health and hormonal contraception

Monica Dragoman, Andrew M. Kaunitz, Michael R. McClung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hormonal contraception, including progestin-only and combined estrogen and progestin methods, represent the majority of commonly used, effective, reversible contraceptives available. However, observed changes in bone mineral density (BMD) among users of these methods have prompted concerns about skeletal health. This chapter aims to review current knowledge about the association between hormonal contraception and bone density, and the observed or possible consequences of those changes resulting from exposure at various time points across the life cycle. In addition, the hypoestrogenic effects of lactation will be considered in this discussion. Most of the chapter focuses on the impact of hormonal contraceptive use on bone health in healthy women and adolescents. In addition, consideration will also be given to the use of hormonal contraception in women at elevated risk for impaired bone health.

Original languageEnglish (US)
Title of host publicationContraception for the Medically Challenging Patient
PublisherSpringer New York
Pages287-306
Number of pages20
ISBN (Print)9781493912339, 9781493912322
DOIs
StatePublished - Jan 1 2014

Fingerprint

Contraception
Progestins
Contraceptive Agents
Bone and Bones
Bone Density
Health
Life Cycle Stages
Lactation
Estrogens

ASJC Scopus subject areas

  • Health Professions(all)
  • Medicine(all)

Cite this

Dragoman, M., Kaunitz, A. M., & McClung, M. R. (2014). Bone health and hormonal contraception. In Contraception for the Medically Challenging Patient (pp. 287-306). Springer New York. https://doi.org/10.1007/978-1-4939-1233-9_16

Bone health and hormonal contraception. / Dragoman, Monica; Kaunitz, Andrew M.; McClung, Michael R.

Contraception for the Medically Challenging Patient. Springer New York, 2014. p. 287-306.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dragoman, M, Kaunitz, AM & McClung, MR 2014, Bone health and hormonal contraception. in Contraception for the Medically Challenging Patient. Springer New York, pp. 287-306. https://doi.org/10.1007/978-1-4939-1233-9_16
Dragoman M, Kaunitz AM, McClung MR. Bone health and hormonal contraception. In Contraception for the Medically Challenging Patient. Springer New York. 2014. p. 287-306 https://doi.org/10.1007/978-1-4939-1233-9_16
Dragoman, Monica ; Kaunitz, Andrew M. ; McClung, Michael R. / Bone health and hormonal contraception. Contraception for the Medically Challenging Patient. Springer New York, 2014. pp. 287-306
@inbook{44fc699352a94fc98a0ff5b70fb026bb,
title = "Bone health and hormonal contraception",
abstract = "Hormonal contraception, including progestin-only and combined estrogen and progestin methods, represent the majority of commonly used, effective, reversible contraceptives available. However, observed changes in bone mineral density (BMD) among users of these methods have prompted concerns about skeletal health. This chapter aims to review current knowledge about the association between hormonal contraception and bone density, and the observed or possible consequences of those changes resulting from exposure at various time points across the life cycle. In addition, the hypoestrogenic effects of lactation will be considered in this discussion. Most of the chapter focuses on the impact of hormonal contraceptive use on bone health in healthy women and adolescents. In addition, consideration will also be given to the use of hormonal contraception in women at elevated risk for impaired bone health.",
author = "Monica Dragoman and Kaunitz, {Andrew M.} and McClung, {Michael R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-1233-9_16",
language = "English (US)",
isbn = "9781493912339",
pages = "287--306",
booktitle = "Contraception for the Medically Challenging Patient",
publisher = "Springer New York",

}

TY - CHAP

T1 - Bone health and hormonal contraception

AU - Dragoman, Monica

AU - Kaunitz, Andrew M.

AU - McClung, Michael R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Hormonal contraception, including progestin-only and combined estrogen and progestin methods, represent the majority of commonly used, effective, reversible contraceptives available. However, observed changes in bone mineral density (BMD) among users of these methods have prompted concerns about skeletal health. This chapter aims to review current knowledge about the association between hormonal contraception and bone density, and the observed or possible consequences of those changes resulting from exposure at various time points across the life cycle. In addition, the hypoestrogenic effects of lactation will be considered in this discussion. Most of the chapter focuses on the impact of hormonal contraceptive use on bone health in healthy women and adolescents. In addition, consideration will also be given to the use of hormonal contraception in women at elevated risk for impaired bone health.

AB - Hormonal contraception, including progestin-only and combined estrogen and progestin methods, represent the majority of commonly used, effective, reversible contraceptives available. However, observed changes in bone mineral density (BMD) among users of these methods have prompted concerns about skeletal health. This chapter aims to review current knowledge about the association between hormonal contraception and bone density, and the observed or possible consequences of those changes resulting from exposure at various time points across the life cycle. In addition, the hypoestrogenic effects of lactation will be considered in this discussion. Most of the chapter focuses on the impact of hormonal contraceptive use on bone health in healthy women and adolescents. In addition, consideration will also be given to the use of hormonal contraception in women at elevated risk for impaired bone health.

UR - http://www.scopus.com/inward/record.url?scp=84956842939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956842939&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1233-9_16

DO - 10.1007/978-1-4939-1233-9_16

M3 - Chapter

SN - 9781493912339

SN - 9781493912322

SP - 287

EP - 306

BT - Contraception for the Medically Challenging Patient

PB - Springer New York

ER -